These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 25720817

  • 1. Investigation of solubilising effects of bile salts on an active pharmaceutical ingredient with unusual pH dependent solubility by NMR spectroscopy.
    Vogtherr M, Marx A, Mieden AC, Saal C.
    Eur J Pharm Biopharm; 2015 May; 92():32-41. PubMed ID: 25720817
    [Abstract] [Full Text] [Related]

  • 2. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF, Joyce SA, Gahan CG, Griffin BT.
    Mol Pharm; 2017 Apr 03; 14(4):1251-1263. PubMed ID: 28186768
    [Abstract] [Full Text] [Related]

  • 3. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
    Dening TJ, Douglas JT, Hageman MJ.
    Mol Pharm; 2021 Aug 02; 18(8):3086-3098. PubMed ID: 34255531
    [Abstract] [Full Text] [Related]

  • 4. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
    Zhou Z, Dunn C, Khadra I, Wilson CG, Halbert GW.
    Eur J Pharm Sci; 2017 Mar 01; 99():95-104. PubMed ID: 27940083
    [Abstract] [Full Text] [Related]

  • 5. Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids.
    Zughaid H, Forbes B, Martin GP, Patel N.
    Int J Pharm; 2012 Jan 17; 422(1-2):295-301. PubMed ID: 22101287
    [Abstract] [Full Text] [Related]

  • 6. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS, Gao Y, Raina SA, Zhang GGZ, Taylor LS.
    Pharm Res; 2018 Jun 18; 35(8):158. PubMed ID: 29916053
    [Abstract] [Full Text] [Related]

  • 7. Methodology for phase selection of a weak basic drug candidate, utilizing kinetic solubility profiles in bio-relevant media.
    Furukawa S, Zhao C, Ohki Y.
    Eur J Pharm Biopharm; 2010 Feb 18; 74(2):298-303. PubMed ID: 19815062
    [Abstract] [Full Text] [Related]

  • 8. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
    Söderlind E, Karlsson E, Carlsson A, Kong R, Lenz A, Lindborg S, Sheng JJ.
    Mol Pharm; 2010 Oct 04; 7(5):1498-507. PubMed ID: 20698569
    [Abstract] [Full Text] [Related]

  • 9. Excluded volume effect of rat intestinal mucin on taurocholate/phosphatidylcholine mixed micelles.
    Wiedmann TS, Liang W, Herrington H.
    J Colloid Interface Sci; 2004 Feb 15; 270(2):321-8. PubMed ID: 14697697
    [Abstract] [Full Text] [Related]

  • 10. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
    Elvang PA, Hinna AH, Brouwers J, Hens B, Augustijns P, Brandl M.
    J Pharm Sci; 2016 Sep 15; 105(9):2832-2839. PubMed ID: 27103012
    [Abstract] [Full Text] [Related]

  • 11. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy.
    Pigliacelli C, Belton P, Wilde P, Qi S.
    J Colloid Interface Sci; 2019 Sep 01; 551():147-154. PubMed ID: 31075629
    [Abstract] [Full Text] [Related]

  • 12. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F, Beck B, Oth M, Augustijns P.
    Int J Pharm; 2004 Apr 15; 274(1-2):221-32. PubMed ID: 15072798
    [Abstract] [Full Text] [Related]

  • 13. Dissolution rate of griseofulvin in bile salt solutions.
    de Smidt JH, Offringa JC, Crommelin DJ.
    J Pharm Sci; 1991 Apr 15; 80(4):399-401. PubMed ID: 1865343
    [Abstract] [Full Text] [Related]

  • 14. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
    Fuchs A, Leigh M, Kloefer B, Dressman JB.
    Eur J Pharm Biopharm; 2015 Aug 15; 94():229-40. PubMed ID: 26032292
    [Abstract] [Full Text] [Related]

  • 15. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
    Fagerberg JH, Al-Tikriti Y, Ragnarsson G, Bergström CA.
    Mol Pharm; 2012 Jul 02; 9(7):1942-52. PubMed ID: 22651218
    [Abstract] [Full Text] [Related]

  • 16. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H, Löbenberg R.
    Eur J Pharm Sci; 2006 Sep 02; 29(1):45-52. PubMed ID: 16815694
    [Abstract] [Full Text] [Related]

  • 17. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST, Frank KJ, Fricker G, Brandl M.
    Eur J Pharm Sci; 2013 Sep 27; 50(1):8-16. PubMed ID: 23583787
    [Abstract] [Full Text] [Related]

  • 18. Geometrical and Structural Dynamics of Imatinib within Biorelevant Colloids.
    Wiest J, Saedtler M, Böttcher B, Grüne M, Reggane M, Galli B, Holzgrabe U, Meinel L.
    Mol Pharm; 2018 Oct 01; 15(10):4470-4480. PubMed ID: 30111113
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the diffusion of bile salt/phospholipid micelles in rat intestinal mucin.
    Wiedmann TS, Herrington H, Deye C, Kallick D.
    Chem Phys Lipids; 2001 Jul 01; 112(1):81-92. PubMed ID: 11518575
    [Abstract] [Full Text] [Related]

  • 20. Effect on the partition equilibrium of various drugs by the formation of mixed bile salt/phosphatidylcholine/fatty acid micelles. A characterization by micellar affinity capillary electrophoresis. Part IV.
    Schawrz MA, Raith K, Dongowski G, Neubert RH.
    J Chromatogr A; 1998 Jun 05; 809(1-2):219-29. PubMed ID: 9677716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.